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Reply to Hauser et al
TO THE EDITOR—We appreciate the letter
by Hauser and colleagues [1] describing
an outbreak of Pneumocystis pneumonia
in Frankfurt [2]. The outbreak appears to
be caused by the same strain of Pneumo-
cystis, which we have called the European
Renal Transplant (ERT) strain, that we
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had previously shown was responsible for
outbreaks in Munich and Zurich [3–5].
This observation reﬂects the importance
of strain typing, but also highlights the
need for well-conducted epidemiologic
investigations to better understand the
source and mode of Pneumocystis infec-
tion transmission in these populations.
It is now clear from multiple reports
that outbreaks of Pneumocystis pneumonia
can be caused by a single strain of the or-
ganism, and that close contact among sus-
ceptible individuals may be responsible for
the transmission of the organism andmain-
tenance of the outbreak (reviewed in [6]).
The Lyon outbreak appeared to involve 1
of the most prevalent strains (based on
typing by single-strand conformational
polymorphism analysis) [7], and thus may
have simply reﬂected exposure to that strain.
However, the available data argue against
that explanation in these 3 related out-
breaks, when it is taken into account that
none of the 11 isolates (6 from Munich, 3
from Zurich, and 2 from Frankfurt) obtain-
ed contemporaneously from non-outbreak
patients were the ERT strain [1, 3].
Only 4 isolates were sequenced, and
thus it is possible that other Pneumocystis
strains were responsible for the additional
26 cases identiﬁed in the Frankfurt out-
break [2]. Nonetheless, it is striking that 3
outbreaks of PCP in 3 cities approximate-
ly 300 to 400 km apart were associated
with a single strain of Pneumocystis. We
agree that typing of additional contempo-
raneous isolates from endemic cases as
well as from individuals with subclinical
Pneumocystis infection would be needed
to clarify the epidemiology. However,
since these outbreaks occurred approxi-
mately 5–7 years ago, it would be very
difﬁcult to obtain such samples or retro-
spectively perform a detailed epidemio-
logic investigation to try to identify
sources of infection that may have linked
the outbreaks. Based on these observa-
tions, it is critical that future outbreaks be
diligently investigated so that we may
better understand the sources of infection
and the mode of transmission, and to
determine if the ERT strain or other
strains are associated with multiple out-
breaks. We currently do not have the
tools to readily identify and study viru-
lence factors due to an inability to culture
the organism and a lack of a genome se-
quence for P. jirovecii. However, once
these tools become available, they need to
be applied to better understand the
biology of this infection. Until then, we
feel that strain typing plays an important
role in elucidating the transmission dy-
namics of Pneumocystis infection.
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